NBD AI Bulletin - Guangdong Hec Technology Holding Co Ltd (the Company, SH 600673, close price: 5.1 yuan) announced on February 26 that the Company's shareholder Yichang Hec Pharmaceutical Co., Ltd. pledged 30 million shares on February 25, 2021, accounting for 5.5% of its holdings. Yichang Hec Pharmaceutical Co., Ltd., person acting in concert of the Company's controlling shareholder, holds about 545 million shares in the Company, accounting for 18.08% of the Company's total equity. As of the new pledge, Yichang Hec Pharmaceutical Co., Ltd. has cumulatively pledged about 478 million shares, accounting for 87.79% of its shareholding in the Company. As at the date of this notice, the cumulative number of pledged shares of the Company's controlling shareholder was about 661 million shares, accounting for 78.4% of its shareholdings, and the cumulative number of pledged shares of the Company's controlling shareholder and its person acting in concert was about 1.358 billion shares, representing 84.52% of their combined holdings.
The semi-annual report shows that Guangdong HEC Technology Holding Co Ltd mainly engages in pharmaceutical products, alloy materials, electronic new materials, chemicals, accounting for 34.69%, 26.2%, 26.07%, 9.07% of its revenue, respectively.
Guangdong HEC Technology Holding Co Ltd's chairman is Zhang Hongwei, male, 49 years old, Chinese national, no overseas permanent residency, undergraduate degree. Guangdong HEC Technology Holding Co Ltd's general manager is Li Yitao, male, Chinese national, no overseas residency, PhD degree, senior engineer.
Tips on "Stock Trends":
1. The number of shares held by northbound investors in the Company increased by 16.5547 million in the past 30 days, representing 0.68% of the Company's circulating shares;
2. There was no institutional research on the Company in the past 30 days.
(By Lan Suying)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.